Who is sponsoring NCT02283931?

NCT02283931 is sponsored by Brigham and Women's Hospital.

What drugs are being tested in NCT02283931?

Interventions in NCT02283931: TTE / NICOM.

What condition does NCT02283931 study?

NCT02283931 studies Obstetric Anesthesia, Cardiac Monitoring.

Is NCT02283931 still recruiting?

NCT02283931 is currently suspended. Last updated 3 August 2022.

Last reviewed 2022-08-03 · How we verify

NCT02283931: LUDCO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac Output Changes With Uterine Displacement

Suspended NA Last updated 3 August 2022

What this trial tests

NA trial testing TTE / NICOM in Obstetric Anesthesia, Cardiac Monitoring in 25 participants. Suspended.

Timeline

1 January 2015

Primary endpoint
30 June 2023

30 December 2023

Quick facts

Lead sponsor	Brigham and Women's Hospital
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	diagnostic
Enrollment	25
Start date	1 January 2015
Primary completion	30 June 2023
Estimated completion	30 December 2023
Sites	1 location across United States

Drugs / interventions tested

TTE / NICOM

Conditions studied

Obstetric Anesthesia, Cardiac Monitoring — all drugs for Obstetric Anesthesia, Cardiac Monitoring →

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 50, female only, with Obstetric Anesthesia, Cardiac Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is currently little information regarding the hemodynamic differences in uterine displacement techniques. Previous studies examining the hemodynamic effects of uterine displacement maneuvers have focused on incidence of hypotension and use of ephedrine. Noninvasive cardiac output monitoring (NICOM) and transthoracic echocardiography (TTE) are becoming popular techniques in anesthesiology because they can provide noninvasive, valid, and precise hemodynamic data.There has been no study specifically examining the hemodynamic differences between the uterine displacement techniques using NICOM or TTE. While all three uterine displacement techniques are recommended, whether one technique may maximize maternal cardiac output is currently unknown.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02283931 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 3 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02283931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing